Built for Biotech℠

Premier Research, a global clinical research, product development, and consulting company, is dedicated to helping the most innovative biotech, specialty pharma and medtech companies take their best ideas from concept to commercialization. Our clinical research, product development and consulting offering bring a unique blend of industry acumen, global compliance and therapeutic expertise to support complex clinical programs with specialized patient populations and significant unmet needs.

Our Built for Biotech℠ model recognizes the importance of providing a holistic approach to the many layers and facets of clinical research. Let’s put this into perspective. Your compound may treat a particular cancer, but requires orphan drug designation for fast-track approval, a special adaptive design to accelerate study timelines, the need to enroll pediatric patients, interaction with patient advocacy organizations and careful strategies to ensure patients and their families are properly engaged to maximize retention. Our project teams are experts in this type of comprehensive delivery, supported by a flexible and agile corporate culture.

We offer cross-functional, customized solutions to meet you wherever you are in your development journey. From rare and orphan diseases, to oncology and hematology, to cell and gene therapies and medtech, our teams are here to serve as an extension of your team across all stages of development.


More than a technology platform, discover how ePremier unifies Premier Research’s data-driven process, people, and resources to help propel biotech innovation.




  • The promise of gene therapy is to provide transformative treatments that meaningfully improve quality of life for patients, many of whom are currently living with debilitating diseases. Explore the emerging landscape of gene therapy and high-level considerations for studies of these advanced therapeutics in this blog.

  • Explore the key considerations for designing successful gene therapy trials in the available blog.

  • A European biotech company was conducting a pediatric trial involving a rare, incurable genetic disorder. In addition to new regulatory considerations, this trial also called for an extremely challenging intracerebral administration. To succeed, they needed a partner that could develop a clear, compliant strategy for obtaining informed consent and implementing an innovative data management plan to track patients between surgical and clinical sites.



Premier Research

3800 Paramount Parkway Suite 400

Morrisville, NC 27560-6949


Phone: + 1 910 447 3156

Contact: N/A